PASITHEA THERAPEUTICS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
PASITHEA THERAPEUTICS CORP. (KTTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $1.27 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $1.27.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.77.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.77.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $23.58.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $1.27 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.77 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.77 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $23.58 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $23.58 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $22.41 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $21.17 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $20.21 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $8.13 10-Q · filed 2024-05-14 | |
| 2024-01-01 | $32.38 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $2.28 10-K · filed 2023-03-30 | |
| 2022-09-30 | $2.68 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.69 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.81 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $4.31 10-K · filed 2023-03-30 | $5.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |